TY - JOUR
T1 - Transcatheter valve implantation for patients with aortic stenosis
T2 - A position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
AU - Vahanian, Alec
AU - Alfieri, Ottavio
AU - Al-Attar, Nawwar
AU - Antunes, Manuel
AU - Bax, Jeroen
AU - Cormier, Bertrand
AU - Cribier, Alain
AU - De Jaegere, Peter
AU - Fournial, Gerard
AU - Kappetein, Arie Pieter
AU - Kovac, Jan
AU - Ludgate, Susanne
AU - Maisano, Francesco
AU - Moat, Neil
AU - Mohr, Friedrich
AU - Nataf, Patrick
AU - Piérard, Luc
AU - Pomar, José Luis
AU - Schofer, Joachim
AU - Tornos, Pilar
AU - Tuzcu, Murat
AU - Van Hout, Ben
AU - Von Segesser, Ludwig K.
AU - Walther, Thomas
PY - 2008/6
Y1 - 2008/6
N2 - Aims: To critically review the available transcatheter aortic valve implantation techniques and their results, as well as propose recommendations for their use and development. Methods and results: A committee of experts including European Association of Cardio-Thoracic Surgery and European Society of Cardiology representatives met to reach a consensus based on the analysis of the available data obtained with transcatheter aortic valve implantation and their own experience. The evidence suggests that this technique is feasible and provides haemodynamic and clinical improvement for up to 2 years in patients with severe symptomatic aortic stenosis at high risk or with contraindications for surgery. Questions remain mainly concerning safety and long-term durability, which have to be assessed. Surgeons and cardiologists working as a team should select candidates, perform the procedure, and assess the results. Today, the use of this technique should be restricted to high-risk patients or those with contraindications for surgery. However, this may be extended to lower risk patients if the initial promise holds to be true after careful evaluation. Conclusion: Transcatheter aortic valve implantation is a promising technique, which may offer an alternative to conventional surgery for high-risk patients with aortic stenosis. Today, careful evaluation is needed to avoid the risk of uncontrolled diffusion.
AB - Aims: To critically review the available transcatheter aortic valve implantation techniques and their results, as well as propose recommendations for their use and development. Methods and results: A committee of experts including European Association of Cardio-Thoracic Surgery and European Society of Cardiology representatives met to reach a consensus based on the analysis of the available data obtained with transcatheter aortic valve implantation and their own experience. The evidence suggests that this technique is feasible and provides haemodynamic and clinical improvement for up to 2 years in patients with severe symptomatic aortic stenosis at high risk or with contraindications for surgery. Questions remain mainly concerning safety and long-term durability, which have to be assessed. Surgeons and cardiologists working as a team should select candidates, perform the procedure, and assess the results. Today, the use of this technique should be restricted to high-risk patients or those with contraindications for surgery. However, this may be extended to lower risk patients if the initial promise holds to be true after careful evaluation. Conclusion: Transcatheter aortic valve implantation is a promising technique, which may offer an alternative to conventional surgery for high-risk patients with aortic stenosis. Today, careful evaluation is needed to avoid the risk of uncontrolled diffusion.
KW - Aortic stenosis
KW - Percutaneous valve interventions
KW - Valve disease
UR - http://www.scopus.com/inward/record.url?scp=44949107279&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=44949107279&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/ehn183
DO - 10.1093/eurheartj/ehn183
M3 - Article
C2 - 18474941
AN - SCOPUS:44949107279
VL - 29
SP - 1463
EP - 1470
JO - European Heart Journal
JF - European Heart Journal
SN - 0195-668X
IS - 11
ER -